Skip to main content

O'Day Daniel Patrick's Form 4 filing

Gilead Sciences, Inc.GILD · filed Sep 30, 2025

Accession no.
0001638643-25-000009
Filed
Sep 30, 2025
Trade date
Sep 29, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $1.12M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
O'Day Daniel PatrickCIK 0001638643Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 29, 2025Common StockSSaleDisposed−8,039$111.47F2−$896,107.33593,164Direct
Sep 29, 2025Common StockSSaleDisposed−1,961$112.42F3−$220,455.62591,203Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Sale prices reported for the transactions reported here range from $110.97 to $111.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F3

Sale prices reported for the transactions reported here range from $112.00 to $112.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)